跳至主要内容
临床试验/NCT05570981
NCT05570981招募中不适用

A Comprehensive Evaluation of the Impact of ATP on Laryngeal Symptoms, Hypersensitivity and Function - an Observational Controlled Study

Bispebjerg Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年11月28日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Change in laryngeal relaxation time (seconds) during challenge testing

研究概览

简要总结

OBJECTIVES

  • To deliver a comprehensive model of laryngeal assessment, evaluating both the sensory and motor components of upper airway control and to relate this to symptom disturbance.
  • Determine if laryngeal control is altered by coughing and the impact of repeated coughing on overall laryngeal control and relaxation to its baseline state.
  • Evaluate if cell damage and tissue inflammation (including exposure to ATP) modulates laryngeal hypersensitivity and function, by using a comprehensive array of test modalities.

AIM To utilise state-of-the-art comprehensive assessment tools to evaluate laryngeal hypersensitivity and function in a cohort of individuals with chronic refractory cough and control subjects. The test modalities utilise direct stimulation of the laryngeal adductor reflex, measurement of laryngeal EMG and assessment of functional laryngeal response to an inhalational challenge with laryngoscopic techniques.

HYPOTHESIS Physiological markers of laryngeal hypersensitivity and dysfunction are highly prevalent in patients with chronic refractory cough and manifestations are driven by ATP stimulation.

OUTCOME MEASURES Measurements of laryngeal symptomatology will be measured over a run-in period and during challenge testing. Laryngeal relaxation will be studied using our novel tracking software capability, combining endoscopic imaging and physiological measurements of diaphragm activation.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Change in laryngeal relaxation time (seconds) during challenge testing

时间窗: At baseline and immediately after challenge testing

Change in time for glottic angle to normalise (i.e. achieve a value equal to or above the value prior to sensory stimulus)

Maximal decrease in glottic anterior angle (degrees) during challenge testing

时间窗: Baseline measurement is taken immediately before beginning the challenge test. Minimal value is taken from continuously measured glottic anterior angle, from immediately after baseline measurement and until immediately after challenge testing

The maximal decrease in glottic anterior angle during challenge testing

Maximal increase in glottic anterior angle (degrees) after challenge testing

时间窗: During challenge testing and from immediately after challenge testing until 5 minutes after challenge testing

The difference between the minimal glottic anterior angle observed during challenge testing and the maximal glottic anterior angle observed from immediately after challenge testing and until 5 minutes after challenge testing

Maximal laryngeal relaxation time (seconds)

时间窗: At baseline, during challenge testing and from immediately after challenge testing until 5 minutes after challenge testing

Maximum time for glottic angle to normalise (i.e. achieve a value equal to or above the value prior to sensory stimulus)

Change in laryngeal relaxation time (seconds) in recovery

时间窗: Immediately after challenge testing and at 5 minutes after challenge testing

Change in time for glottic angle to normalise (i.e. achieve a value equal to or above the value prior to sensory stimulus)

次要结局

  • Cough VAS (0-100 mm)(At baseline, during challenge testing at minutes 0:30, 1:00, 1:30, 2:00, 2:30, 3:00, 3:30 and 4:00 (from immediately after an administered dose of ATP and until 15 seconds after an administered dose) and immediately after challenge testing)
  • Cough count and frequency(At baseline, during challenge testing at minutes 0:30, 1:00, 1:30, 2:00, 2:30, 3:00, 3:30 and 4:00 (from immediately after an administered dose of ATP and until 15 seconds after an administered dose) and immediately after challenge testing)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Emil Walsted

Principal Investigator

Bispebjerg Hospital

研究点 (1)

Loading locations...

相似试验